[1] |
Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update [J]. Fertil Steril, 2012, 98(3): 572-529. DOI: 10.1016/j.fertnstert.2012.06.044.
|
[2] |
Walentowicz-Sadlecka M, Sadlecki P, Bodnar M, et al. Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients [J]. PLoS One, 2014, 9(1): e84629. DOI: 10.1371/journal.pone.0084629.
|
[3] |
Leconte M, Chouzenoux S, Nicco C, et al. Role of the CXCL12-CXCR4 axis in the development of deep rectal endometriosis [J]. J Reprod Immunol, 2014, 103: 45-52. DOI: 10.1016/j.jri.2013.12.121.
|
[4] |
|
[5] |
Li J, Yin G, Chen M, et al. Expression of CXCL12 and its receptor CXCR4 in patients with adenomyosis [J]. Oncol Lett, 2017, 13(4): 2731-2736. DOI: 10.3892/ol.2017.5762.
|
[6] |
Hara T, Tanegashima K. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis [J]. Biomol Concepts, 2014, 5(2): 167-173. DOI: 10.1515/bmc-2014-0007.
|
[7] |
Krikun G. The CXL12/CXCR4/CXCR7 axis in female reproductive tract disease: review [J]. Am J Reprod Immunol, 2018, 80(5): e13028. DOI: 10.1111/aji.13028.
|
[8] |
谢幸,孔北华,段涛. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 268, 304.
|
[9] |
Huang TS, Chen YJ, Chou TY, et al. Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells [J]. J Cell Mol Med, 2014, 18(7): 1358-1371. DOI: 10.1111/jcmm.12300.
|
[10] |
Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis [J]. Hum Reprod Update, 2014, 20(3): 386-402. DOI: 10.1093/humupd/dmt052.
|
[11] |
Tsutsumi A, Okada H, Nakamoto T, et al. Estrogen induces stromal cell-derived factor 1 (SDF-1/CXCL12) production in human endometrial stromal cells: a possible role of endometrial epithelial cell growth [J]. Fertil Steril, 2011, 95(1): 444-447. DOI: 10.1016/j.fertnstert.2010.08.037.
|
[12] |
Zheng N, Chen J, Li T, et al. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention [J]. Mol Carcinog, 2017, 56(8): 1896-1908. DOI: 10.1002/mc.22645.
|
[13] |
Zhou WH, Wu X, Hu WD, et al. Co-expression of CXCR4 and CXCR7 in human endometrial stromal cells is modulated by steroid hormones [J]. Int J Clin Exp Pathol, 2015, 8(3): 2449-2460.
|
[14] |
Uto-Konomi A, McKibben B, Wirtz J, et al. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4 [J]. Biochem Biophys Res Commun, 2013, 431(4): 772-776. DOI: 10.1016/j.bbrc.2013.01.032.
|
[15] |
Han Y, Wu C, Wang J, et al. CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment [J]. Tumour Biol, 2017, 39(5): 1010428317701631. DOI: 10.1177/1010428317701631.
|
[16] |
|
[17] |
Zabel BA, Lewén S, Berahovich RD, et al. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells [J]. Mol Can, 2011, 10: 73. DOI: 10.1186/1476-4598-10-73.
|